Legal Opinion of Beijing Zhonglun Law Firm on the adjustments and grants related to Ganli Pharmaceutical Co., Ltd.'s 2024 Restricted Stock Incentive Plan

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.